Approved HIP Breast Cancer Screening Trial Projects
Here you can browse the complete list of projects for HIP Breast Cancer Screening Trial whose requests for data/biospecimens were approved.
Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
---|---|---|---|---|---|
Surrogate endpoints for cancer screening trials | Adam Brentnall | Queen Mary University of London | HIPB | Nov 14, 2024 | HIPB-15 |
Heterogeneous treatment effect estimation using instrumental variable in time-to-event data | Uri Shalit | Technion - Israel Institute of Technology | HIPB | May 13, 2024 | HIPB-13 |
Treatment effect in a proportional hazards model with instrumental variables | lorenzo tedesco | KU LEUVEN | HIPB | Dec 5, 2022 | HIPB-10 |
Use of prescriptive analytics in the desing of dynamic treatment regimes for breast cancer. | Gustavo Mendoza Olguin | Autonomous University of Puebla | HIPB | Jun 14, 2022 | HIPB-9 |
Designing personal treatment for breast cancer | Nan Wang | Dalian University of Technology | HIPB | Mar 25, 2022 | HIPB-8 |
Epidemiologic investigation of breast cancer cases diagnosed in a large histopathological practice | Axel Niendorf | MVZ Prof. Dr. med. A. Niendorf Pathologie Hamburg-West GmbH | HIPB | Sep 17, 2021 | HIPB-6 |
Quantitative analysis on the design of the project of multi-cancer early detection trial | Ping Hu | NCI | HIPB | Jul 30, 2021 | HIPB-4 |
Nonparametric instrumental regression with competing risks data | Ingrid Van Keilegom | Katholieke Universiteit Leuven | HIPB | Mar 1, 2021 | HIPB-2 |